)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Central Pharmaceutical Joint Stock Company No3
Central Pharmaceutical Joint Stock Company No3 (DP3) investor relations material
Central Pharmaceutical Joint Stock Company No3 has been private
Central Pharmaceutical Joint Stock Company No3 Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary20 Apr, 2026
Executive summary
Net revenue for Q1 2026 reached VND 134.98 billion, up 47% year-over-year from VND 91.90 billion.
Profit after tax for Q1 2026 was VND 34.78 billion, a 46% increase compared to VND 23.86 billion in Q1 2025.
Gross profit margin improved, with gross profit at VND 39.88 billion versus VND 31.04 billion last year.
Financial highlights
Operating profit for Q1 2026 was VND 43.31 billion, up from VND 29.57 billion year-over-year.
Financial income rose to VND 2.45 billion from VND 1.27 billion, while financial expenses increased to VND 582.6 million.
Basic EPS for Q1 2026 was VND 1,618, up from VND 1,110 in Q1 2025.
Total assets at March 31, 2026 were VND 795.05 billion, up from VND 756.09 billion at the start of the year.
Cash and cash equivalents at quarter-end were VND 3.71 billion, down from VND 4.48 billion at year-beginning.
Outlook and guidance
No explicit forward-looking guidance provided, but strong Q1 growth in revenue and profit signals positive momentum.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Central Pharmaceutical Joint Stock Company No3
- Net profit after tax surged 26.8% to VND 153.6 billion in 2025, with strong revenue growth.DP3
Q4 202521 Jan 2026 - Net profit and revenue rose year-over-year, but liquidity declined due to investments and dividends.DP3Q3 202529 Dec 2025
- Q2/2025 net profit increased to VND 32.10 billion as margins and cash flow improved.DP3Q2 202525 Jul 2025
- Q3 2024 delivered higher profit and margin, but nine-month results reflect ongoing market headwinds.DP3Q3 202413 Jun 2025
- H1 2024 saw lower profit and revenue, but improved cash and zero borrowings.DP3Q2 202413 Jun 2025
- 2024 net revenue rose 1.9% and gross margin improved, but net profit slipped 3.3%.DP3Q4 20246 Jun 2025
- Net profit grew 8.3% year-over-year in Q1 2025, with improved cash flow and margins.DP3Q1 20256 Jun 2025
Next Central Pharmaceutical Joint Stock Company No3 earnings date
Q2 202617 Jul, 2026
Central Pharmaceutical Joint Stock Company No3
Next Central Pharmaceutical Joint Stock Company No3 earnings date
Q2 202617 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage